O

Organovo Holdings
D

ONVO

0.35500
USD
-0.02
(-5.61%)
مغلق
حجم التداول
1,800
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
5,454,868
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    E
    EDIT
    0.15000
    (12.50%)
    1.35000 USD
    E
    EXAS
    0.520
    (0.96%)
    54.780 USD
    N
    NTLA
    1.040
    (10.45%)
    10.990 USD
    P
    PACB
    0.11000
    (6.49%)
    1.80500 USD
    S
    STEM
    -0.03200
    (-4.56%)
    0.66950 USD
    T
    TDOC
    0.38500
    (4.06%)
    9.87500 USD
    V
    VCEL
    -1.110
    (-1.87%)
    58.390 USD
    المزيد
الأخبار
المقالات

العنوان: Organovo Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.